atorvastatin has been researched along with Cardiac Remodeling, Ventricular in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (25.00) | 29.6817 |
| 2010's | 21 (58.33) | 24.3611 |
| 2020's | 6 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Chen, Z; Guo, J; Liu, H; Ma, Y; Peng, X; Wang, Q; Zheng, Z; Zhu, J | 1 |
| Nie, W; Shi, K; Xie, D; Yu, B; Yu, M; Zhang, H | 1 |
| Liang, Z; Ma, T; Sun, D; Zhang, F; Zhang, Y | 1 |
| Gao, RL; Geng, YJ; Huang, J; Huang, PS; Li, N; Lu, MJ; Qian, HY; Qian, J; Shen, R; Song, L; Tian, XQ; Wang, H; Wu, WC; Wu, Y; Xiong, YY; Xu, J; Xu, JY; Yang, YJ; Zhang, J; Zhao, SH | 1 |
| Khairat, I; Khedr, NF; Werida, R | 1 |
| Bian, Z; Chen, X; Ding, Y; Liu, N; Lu, F; Wu, H; Yang, D; Zheng, P | 1 |
| Chang, Y; Chen, Y; Guo, X; Sun, G; Sun, Y; Zhang, N | 1 |
| Huang, J; Li, HH; Liang, FL; Mo, JL; Ou, BQ; Peng, Y; Zhou, Z | 1 |
| Fei, MY; Hu, GP; Liu, ZJ; Shi, QX; Sun, F; Yin, Z | 1 |
| Liu, D; Nie, W; Shi, K; Xie, D; Yang, P; Yu, B; Zhang, H | 1 |
| Chen, W; Gao, G; Ge, L; Jiang, S; Sui, S; Zhai, C; Zhang, S | 1 |
| Chrysohoou, C; Dilaveris, P; Kioufis, S; Maniatis, K; Michalea, S; Miliou, A; Oikonomou, E; Papavassiliou, AG; Siasos, G; Stefanadis, C; Tousoulis, D; Zaromitidou, M | 1 |
| Cao, S; Fang, W; He, Y; Li, R; Li, Y; Wang, J; Xi, S; Zhang, B | 1 |
| An, Z; Dong, N; Ge, LL; He, YQ; Li, SM; Yang, G; Zhang, WQ | 1 |
| Deng, Y; Guo, X; Liu, H; Shang, J; Yuan, X; Zhu, D | 1 |
| Belló-Klein, A; Lehnen, AM; Lehnen, TE; Machado, UF; Markoski, MM; Schaan, B; Tavares, AM | 1 |
| Cheng, WP; Lo, HM; Shyu, KG; Wang, BW | 1 |
| Cheng, B; Geng, QX; Leanne, G; Miao, W; Song, GM; Wang, H; Wang, HT; Wang, W; Zhao, D; Zhao, Z | 1 |
| Cui, W; Du, H; Hao, J; Li, Y; Lu, J; Xiao, B; Yang, X | 1 |
| Carvalho Sposito, A; da Mota Silveira-Filho, L; de Souza Vilarinho, KA; Diógenes de Carvalho, D; Galluce Torina, A; Martins de Oliveira, PP; Pereira do Carmo, HR; Petrucci, O; Reichert, K | 1 |
| Duda, M; Maczewska, J; Maczewski, M | 1 |
| Akioka, H; Anan, F; Hara, M; Iwao, T; Nakagawa, M; Saikawa, T; Takahashi, N; Teshima, Y; Yonemochi, H; Yufu, K | 1 |
| Boyle, A; Connelly, KA; Gilbert, RE; Kelly, D; Kompa, A; Krum, H; Martin, JH; Zhang, Y | 1 |
| Geng, J; Kang, W; Wang, W; Zhang, Y; Zhao, Z; Zhiming, GE | 1 |
| Chen, YL; Li, L; Liu, GQ; Liu, RY; Yang, PL; Zhang, JY; Zhao, XY | 1 |
| Dai, L; Wu, S | 1 |
| Bi, Q; Bolli, R; Dawn, B; Hunt, G; Peng, Y; Sanganalmath, SK; Sato, H; Shirk, G; Tang, XL; Vincent, RJ | 1 |
| Cai, A; Dai, G; Huang, Y; Kuang, J; Mai, W; Qiu, R; Song, Y | 1 |
| Doevendans, PA; Eefting, FD; Goumans, MJ; Post, MC; Post, S; Rensing, BJ; Stella, PR; van den Branden, BJ; van Es, HW; Wildbergh, TX | 1 |
| Fan, YH; Tian, JW; Wang, SW; Xu, L; Yang, XD; Zhang, HT; Zhao, LY; Zheng, QS | 1 |
| Bahlmann, FH; Drexler, H; Engberding, N; Fuchs, M; Haller, H; Heineke, A; Hilfiker-Kleiner, D; Hornig, B; Kotlarz, D; Landmesser, U; Mueller, M; Schaefer, A; Spiekermann, S; Templin, C; Wiencke, A | 1 |
| Bailey, M; Denver, R; Krum, H; Martin, J | 1 |
| Fukunami, M; Kioka, H; Masuda, M; Mine, T; Morita, T; Node, K; Okuda, K; Tamaki, S; Tsukamoto, Y; Yamada, T | 1 |
| Hu, SJ; Kang, L | 1 |
| Ge, CJ; Hu, SJ; Kang, L | 1 |
| Chen, YD; Ge, CJ; Hu, SJ; Ji, Y; Lu, SZ; Wu, XF | 1 |
7 trial(s) available for atorvastatin and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Strengthening effects of bone marrow mononuclear cells with intensive atorvastatin in acute myocardial infarction.
Topics: Adult; Aged; Atorvastatin; Beijing; Bone Marrow Transplantation; Combined Modality Therapy; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Recovery of Function; ST Elevation Myocardial Infarction; Stroke Volume; Time Factors; Transplantation, Autologous; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2020 |
Effect of atorvastatin versus rosuvastatin on inflammatory biomarkers and LV function in type 2 diabetic patients with dyslipidemia.
Topics: Atorvastatin; Biomarkers; Diabetes Mellitus, Type 2; Double-Blind Method; Dyslipidemias; Egypt; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Inflammation Mediators; Lipids; Male; Middle Aged; Prospective Studies; Rosuvastatin Calcium; Time Factors; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2021 |
Effects of Short-term High Dose Atorvastatin on Left Ventricular Remodeling in Patients with First Time Attack of Anterior Acute Myocardial Infarction.
Topics: Adolescent; Adult; Aged; Atorvastatin; C-Reactive Protein; Drug Administration Schedule; Echocardiography; Endothelin-1; Female; Humans; Male; Malondialdehyde; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Middle Aged; Myocardial Infarction; Ventricular Function, Left; Ventricular Remodeling; Young Adult | 2018 |
Dose-dependent effects of short term atorvastatin treatment on arterial wall properties and on indices of left ventricular remodeling in ischemic heart failure.
Topics: Aged; Arteries; Atorvastatin; Cholesterol, LDL; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intercellular Adhesion Molecule-1; Male; Matrix Metalloproteinase 9; Middle Aged; Myocardial Ischemia; Natriuretic Peptide, Brain; Pyrroles; Regression Analysis; Ventricular Remodeling | 2013 |
Early atorvastatin therapy improves cardiac function in patients with acute myocardial infarction.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Atrial Natriuretic Factor; Cholesterol; Echocardiography; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardial Infarction; Natriuretic Peptide, Brain; Prospective Studies; Pyrroles; Stroke Volume; Triglycerides; Ventricular Remodeling | 2009 |
Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial.
Topics: Aged; Atorvastatin; Biomarkers; Chi-Square Distribution; Coronary Circulation; Drug Administration Schedule; Female; Hemodynamics; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Imaging; Male; Microcirculation; Middle Aged; Myocardial Infarction; Myocardium; Netherlands; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Pilot Projects; Predictive Value of Tests; Pyrroles; Time Factors; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2012 |
Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia.
Topics: Aged; Amlodipine; Antihypertensive Agents; Atorvastatin; Blood Pressure; C-Reactive Protein; Drug Synergism; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Hypertrophy, Left Ventricular; Lipids; Male; Middle Aged; Pyrroles; Time Factors; Treatment Outcome; Uric Acid; Ventricular Remodeling | 2008 |
29 other study(ies) available for atorvastatin and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Atorvastatin-induced tolerogenic dendritic cells improve cardiac remodeling by suppressing TLR-4/NF-κB activation after myocardial infarction.
Topics: Animals; Apoptosis; Atorvastatin; Cytokines; Dendritic Cells; Disease Models, Animal; Fibrosis; Mice; Myocardial Infarction; Myocardium; Myocytes, Cardiac; NF-kappa B; Stroke Volume; Toll-Like Receptor 4; Ventricular Function, Left; Ventricular Remodeling | 2023 |
Suppression of miR-143-3p contributes to the anti-fibrosis effect of atorvastatin on myocardial tissues via the modulation of Smad2 activity.
Topics: Animals; Aorta; Atorvastatin; Collagen; Constriction, Pathologic; Disease Models, Animal; Fibroblasts; Fibrosis; Gene Expression Regulation; Humans; MicroRNAs; Myocardium; Rats; Smad2 Protein; Transforming Growth Factor beta1; Ventricular Remodeling | 2020 |
Atorvastatin alleviates left ventricular remodeling in isoproterenol-induced chronic heart failure in rats by regulating the RhoA/Rho kinase signaling pathway.
Topics: Animals; Atorvastatin; Cardiotonic Agents; Chronic Disease; Echocardiography; Heart Failure; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isoproterenol; Male; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; rho GTP-Binding Proteins; rho-Associated Kinases; Signal Transduction; Ventricular Remodeling | 2020 |
Atorvastatin reverses high cholesterol-induced cardiac remodelling and regulates mitochondrial quality-control in a cholesterol-independent manner: An experimental study.
Topics: Animals; Atorvastatin; Diet, High-Fat; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Mice; Mice, Inbred C57BL; Ventricular Remodeling | 2021 |
Atorvastatin Attenuates Myocardial Hypertrophy in Spontaneously Hypertensive Rats via the C/EBPβ/PGC-1α/UCP3 Pathway.
Topics: Animals; Apoptosis; Atorvastatin; Atrial Natriuretic Factor; Blood Pressure; CCAAT-Enhancer-Binding Protein-beta; Echocardiography; Hypertension; Hypertrophy; Male; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Uncoupling Protein 3; Up-Regulation; Ventricular Remodeling | 2018 |
Synergistic Effect of Atorvastatin and Folic Acid on Cardiac Function and Ventricular Remodeling in Chronic Heart Failure Patients with Hyperhomocysteinemia.
Topics: Aged; Aged, 80 and over; Atorvastatin; China; Chronic Disease; Female; Folic Acid; Heart Failure; Heart Function Tests; Humans; Hyperhomocysteinemia; Male; Middle Aged; Ventricular Remodeling | 2018 |
Anti-hypertrophy effect of atorvastatin on myocardium depends on AMPK activation-induced miR-143-3p suppression via Foxo1.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Apoptosis; Atorvastatin; Cell Line; Cell Survival; Disease Models, Animal; Hypertrophy, Left Ventricular; Male; MicroRNAs; Myocytes, Cardiac; Nerve Tissue Proteins; Rats, Sprague-Dawley; Signal Transduction; Ventricular Function, Left; Ventricular Remodeling | 2018 |
Atorvastatin Improves Doxorubicin-Induced Cardiac Dysfunction by Modulating Hsp70, Akt, and MAPK Signaling Pathways.
Topics: Animals; Apoptosis; Atorvastatin; Cardiotoxicity; Caspase 3; Disease Models, Animal; Doxorubicin; Fibrosis; Heart Failure; Heart Ventricles; HSP70 Heat-Shock Proteins; Male; Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats, Wistar; Signal Transduction; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2019 |
Differential expression of Nad(P)H oxidase isoforms and the effects of atorvastatin on cardiac remodeling in two-kidney two-clip hypertensive rats.
Topics: Animals; Atorvastatin; Atrial Natriuretic Factor; Blotting, Western; Fibrosis; Hemodynamics; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Renovascular; Isoenzymes; Male; Membrane Glycoproteins; Myocardium; Myosin Heavy Chains; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Pyrroles; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2013 |
Atorvastatin reduces myocardial fibrosis in a rat model with post-myocardial infarction heart failure by increasing the matrix metalloproteinase-2/tissue matrix metalloproteinase inhibitor-2 ratio.
Topics: Animals; Atorvastatin; Collagen; Disease Models, Animal; Female; Fibrosis; Heart Failure; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Matrix Metalloproteinase 2; Myocardial Infarction; Myocardium; Pyrroles; Rats; Rats, Wistar; Tissue Inhibitor of Metalloproteinase-2; Ventricular Remodeling | 2013 |
Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: partly involvement of TLR-4/MYD88 pathway.
Topics: Animals; Atorvastatin; Cardiomegaly; Cytokines; Heart; Heptanoic Acids; Hypoxia; Male; Myeloid Differentiation Factor 88; Myocardium; Oxidative Stress; Pyrroles; Rats; Rats, Wistar; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Sleep Apnea, Obstructive; Toll-Like Receptor 4; Ventricular Remodeling | 2014 |
Atorvastatin administered before myocardial infarction in rats improves contractility irrespective of metabolic changes.
Topics: Animals; Atorvastatin; Echocardiography; Glucose Transporter Type 4; Heart Ventricles; Heptanoic Acids; Male; Muscle Contraction; Myocardial Infarction; Myocardium; Pyrroles; Rats; Rats, Inbred WKY; Ventricular Remodeling | 2014 |
MicroRNA-208a Increases Myocardial Endoglin Expression and Myocardial Fibrosis in Acute Myocardial Infarction.
Topics: Animals; Atorvastatin; Blotting, Western; Cells, Cultured; Disease Models, Animal; Endoglin; Fibrosis; Gene Expression Regulation; Hemodynamics; Heptanoic Acids; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; Male; MicroRNAs; Muscle Cells; Myocardial Infarction; Polymerase Chain Reaction; Pyrroles; Random Allocation; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Tetrazoles; Valine; Valsartan; Ventricular Remodeling | 2015 |
Augmentation of autophagy by atorvastatin via Akt/mTOR pathway in spontaneously hypertensive rats.
Topics: Animals; Atorvastatin; Autophagy; Blood Pressure; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; TOR Serine-Threonine Kinases; Ventricular Remodeling | 2015 |
Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR Rats.
Topics: Amlodipine; Animals; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Blotting, Western; Drug Combinations; Gene Expression; Hypertension; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Random Allocation; Rats, Inbred SHR; Rats, Inbred WKY; Reverse Transcriptase Polymerase Chain Reaction; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Tissue Inhibitor of Metalloproteinases; Ventricular Remodeling | 2016 |
Atorvastatin Improves Ventricular Remodeling after Myocardial Infarction by Interfering with Collagen Metabolism.
Topics: Animals; Anticholesteremic Agents; Atorvastatin; Catheter Ablation; Collagen; Disease Models, Animal; Fibrosis; Gene Expression; Heart Ventricles; Hemodynamics; Interleukin-1; Male; Matrix Metalloproteinase 1; Myocardial Infarction; Myocardium; NF-kappa B p50 Subunit; Rats; Rats, Wistar; Tissue Inhibitor of Metalloproteinase-1; Ventricular Remodeling | 2016 |
Hypercholesterolaemia exacerbates ventricular remodelling after myocardial infarction in the rat: role of angiotensin II type 1 receptors.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anticholesteremic Agents; Atorvastatin; Drug Therapy, Combination; Echocardiography; Heptanoic Acids; Hypercholesterolemia; Losartan; Male; Myocardial Infarction; Pyrroles; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Up-Regulation; Ventricular Dysfunction, Left; Ventricular Remodeling | 2008 |
Effect of atorvastatin on cardiac remodelling and mortality in rats following hyperglycemia and myocardial infarction.
Topics: Animals; Atorvastatin; Body Weight; Cardiac Volume; Collagen Type I; Collagen Type III; Diabetes Mellitus, Experimental; Disease Models, Animal; Female; Fibrosis; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Myocardial Infarction; Myocardium; Pyrroles; Rats; Rats, Sprague-Dawley; Ventricular Remodeling | 2010 |
Atorvastatin reverses cardiac remodeling possibly through regulation of protein kinase D/myocyte enhancer factor 2D activation in spontaneously hypertensive rats.
Topics: Animals; Atorvastatin; Blood Pressure; Disease Models, Animal; Enzyme Activation; Fibrosis; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hydroxyproline; Hypertension; Hypertrophy, Left Ventricular; Lipids; Male; MEF2 Transcription Factors; Myocardium; Protein Kinase C; Pyrroles; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Time Factors; Transcription Factors; Ventricular Remodeling | 2010 |
Atorvastatin prevents left ventricular remodeling in spontaneously hypertensive rats.
Topics: Animals; Atorvastatin; Connective Tissue Growth Factor; Gene Expression; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrroles; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Ventricular Remodeling | 2010 |
[Atorvastatin attenuates hypoxic pulmonary hypertension in rats by inhibiting RhoA/Rho kinase pathway].
Topics: Animals; Anticholesteremic Agents; Atorvastatin; Hemodynamics; Heptanoic Acids; Hypertension, Pulmonary; Hypoxia; Male; Pulmonary Artery; Pyrroles; Random Allocation; Rats; Rats, Wistar; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Ventricular Remodeling | 2011 |
Atorvastatin therapy during the peri-infarct period attenuates left ventricular dysfunction and remodeling after myocardial infarction.
Topics: Animals; Apoptosis; Atorvastatin; Female; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hydroxyproline; Muscle Contraction; Myocardial Infarction; Myocytes, Cardiac; Pyrroles; Rats; Rats, Inbred F344; Ventricular Dysfunction, Left; Ventricular Remodeling | 2011 |
[Effect of atorvastatin on cardiac function and TGF-β1 signaling pathway after acute myocardial infarction in rats].
Topics: Animals; Atorvastatin; Heart; Heptanoic Acids; Male; Myocardial Infarction; Pyrroles; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad2 Protein; Transforming Growth Factor beta1; Ventricular Remodeling | 2012 |
[Effects of atorvastatin on the proliferation and collagen synthesis of rat cardiac fibroblasts].
Topics: Animals; Animals, Newborn; Atorvastatin; Cell Division; Cells, Cultured; Collagen; Fibroblasts; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardium; Pyrroles; Rats; Rats, Sprague-Dawley; Ventricular Remodeling | 2003 |
Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase.
Topics: Animals; Atorvastatin; Biological Availability; Capillaries; Cells, Cultured; Collateral Circulation; Drug Resistance; Endothelial Cells; Fibrosis; Heart Failure; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Pyrroles; Random Allocation; Ultrasonography; Vasodilation; Ventricular Function, Left; Ventricular Remodeling | 2004 |
In vitro inhibitory effects of atorvastatin on cardiac fibroblasts: implications for ventricular remodelling.
Topics: Angiotensin II; Animals; Atorvastatin; Cells, Cultured; Collagen; Connective Tissue Growth Factor; Dose-Response Relationship, Drug; Extracellular Matrix; Fibroblasts; Heart; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Myocardium; Procollagen; Pyrroles; Rats; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Remodeling | 2005 |
Atorvastatin therapy associated with improvement in left ventricular remodeling in a case of idiopathic dilated cardiomyopathy.
Topics: Adult; Anticholesteremic Agents; Atorvastatin; Cardiomyopathy, Dilated; Cardiovascular Agents; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Pyrroles; Ventricular Remodeling | 2006 |
[Effect of atorvastatin on left ventricular remodeling in spontaneously hypertensive rats].
Topics: Animals; Anticholesteremic Agents; Apoptosis; Atorvastatin; Blood Pressure; Heptanoic Acids; Hydroxyproline; Hypertension; Lipids; Male; Myocardium; Proliferating Cell Nuclear Antigen; Pyrroles; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Up-Regulation; Ventricular Remodeling | 2007 |
Beneficial effect of atorvastatin on left ventricular remodeling in spontaneously hypertensive rats.
Topics: Animals; Apoptosis; Atorvastatin; Blood Pressure; Cardiomegaly; Collagen; Cyclin-Dependent Kinase Inhibitor p27; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Myocardium; Pyrroles; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Ventricular Remodeling | 2007 |